MONO- ODER DISUBSTITUIERTE INDOLDERIVATE ALS DENGUEVIRENREPLIKATIONSHEMMER

European patent · EP3201176 · In force

Register entry

Publication number
EP3201176
Application number
EP15771136
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 30, 2015
Published
Aug 9, 2017
Granted
Dec 12, 2018
Protection ends at the latest
Sep 29, 2035
Next annual fee due
Sep 30, 2026
IPC classes
C07D 209/42 (2006.01)
A61K 31/404 (2006.01)
A61P 31/12 (2006.01)
Priority
EP 14187374 01.10.2014
EP 15159164 16.03.2015
PCT application
PCT/EP2015/072551 30.09.2015
PCT publication
WO2016/050841 07.04.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2025

    Change

    Published in Swissreg on 01.10.2025

  2. Oct 3, 2024

    Change

    Published in Swissreg on 03.10.2024

  3. Oct 1, 2023

    Change

    Published in Swissreg on 01.10.2023

  4. Oct 1, 2022

    Change

    Published in Swissreg on 01.10.2022

  5. Dec 19, 2018

    Granted

    Published in Swissreg on 19.12.2018

Parties

Holder

Janssen Pharmaceuticals, Inc.

1125 Trenton-Harbourton Road, Titusville, NJ 08560, US

KATHOLIEKE UNIVERSITEIT LEUVEN

Katholieke Universiteit Leuven

KU Leuven Research & Development Waaistraat 6, bus 5105, 3000 Leuven, BE

Inventor

RABOISSON, Pierre, Jean-Marie, Bernard

B-2340 Beerse, BE

JONCKERS, Tim, Hugo, Maria

B-2340 Beerse, BE

BARDIOT, Dorothée, Alice, Marie-Eve

B-3001 Leuven (Heverlee), BE

BONFANTI, Jean-François

F-92787 Issy-les-Moulineaux Cedex 9, FR

KESTELEYN, Bart, Rudolf, Romanie

B-2340 Beerse, BE

MARCHAND, Arnaud, Didier, M

B-3001 Leuven (Heverlee), BE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.